Seres Therapeutics shares are trading higher after the company entered a memorandum of understanding with Nestlé Health Science for the sale of its VOWST assets.
Portfolio Pulse from Benzinga Newsdesk
Seres Therapeutics shares are trading higher after the company entered a memorandum of understanding with Nestlé Health Science for the sale of its VOWST assets.
June 06, 2024 | 10:33 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Seres Therapeutics shares are trading higher following the announcement of a memorandum of understanding with Nestlé Health Science for the sale of its VOWST assets.
The news of a memorandum of understanding with Nestlé Health Science for the sale of VOWST assets is a positive development for Seres Therapeutics, likely leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100